In our cohort, MR-proADM levels were significantly different at any time point between survivors and non-survivors with an increasing trend observed in the latter and a decreasing one in the former.
← all excerpts
Effectiveness of Copeptin, MR-proADM and MR-proANP in Predicting Adverse Outcomes, Alone and in Combination with Traditional Severity Scores, a Secondary Analysis in COVID-19 Patients Requiring Intensive Care Admission.
1
—
—